An inorganic Pyrophosphatase isolated from E. coli (patent on process) is the latest addition to Canvax© portfolio of enzymes to contribute to mRNA vaccines Manufacturing. Canvax© announced the release of an improved Inorganic Pyrophosphatase (PPAse), a DNA replication enhancer with high purity (≥ 95%) and enhanced capacity of increasing RNA yield in In Vitro Transcription […]
Learn More
Canvax™ has been highlighted as Leading supplier on the new market research report «Apoptosis Assays Market», published by MarketsandMarkets™. The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%. Learn more clicking in the following link: https://www.marketsandmarkets.com/requestsampleNew.asp?id=9069428&utm_source=OpenPR&utm_medium=Paid
Learn More
Data Bridge Market Research highlighted Canvax Biotech as Key Market Competitor in their last Cell Viability Assays Market Research. The report analyses this market By Product, Application, End-User, Geography and Industry Trends & Forecast to 2026. Get Sample PDF of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-viability-assays-market
Learn More
ODB Bio Investors Meeting, organized by Rabanales 21 and Canaan Research on last 24th November, included in their Expert Committee to Canvax Biotech, and also to Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) and Instituto Municipal de Desarrollo Económico y Empleo de Córdoba (IMDEEC). On the other hand, there were some Investment funds such […]
Learn More
This news, which has been highlighted by more than one hundred national newspapers, has been explained that a trained dog is able to detect whether a person has cancer sickness even before medical tests could determine it. So is how Canvax hast got olfactory proteins with the aim of being able to get a better […]
Learn More
Regional Sales Representative for Basque Country, Cantabria & Navarra. About The Job: We are looking for a freelance Regional Sales Representative to market our 450+ Molecular Biology Products and Services in the assigned area (Basque Country, Cantabria & Navarra). Your tasks: · Achieves annual sales plan and sales targets for assigned area. · Establishes, nurtures […]
Learn More
In today´s edition, Diario Córdoba publishes an interview with Elier Paz, CEO of Canvax Biotech. During the interview, the journalist Irina Marzo asked about most updated information about the company, currents projects inside Drug discovery and lead molecules. For more information, read the full new here.
Learn More
In today´s edition, Diario El mundo dedicates an article to Canvax Biotech. Under the title “A molecular nose to detect tumors”, the writer Pilar Macias asked to Canvax´s CEO about Canvax´s current researches, story, milestones, patents, employees and relations with the University. For more information, read the full new here.
Learn More
The program “Hoy por Hoy” at Cadena Ser interviewed yesteday Elier Paz, CEO of Canvax. During the interview, the broadcaster asked him about Canvax´s current researches, patents, employees and relations with the University. To listen the full interview click here.
Learn More
In their analysis about biotech sector in Andalucía, the journal Diario Expansión has highlighted the important commitment of Canvax Biotech for the development of new products and technologies that can help researchers to carry out their daily investigations. As referred in the article, Canvax has been the Andalusian biotech company that has launched more new […]
Learn More